BEAM
Price
$23.89
Change
-$0.47 (-1.93%)
Updated
Nov 5, 04:55 PM (EDT)
Earnings call today
FATE
Price
$2.67
Change
-$0.09 (-3.26%)
Updated
Nov 5, 04:00 PM (EDT)
118 days until earnings call
Ad is loading...

BEAM vs FATE

Header iconBEAM vs FATE Comparison
Open Charts BEAM vs FATEBanner chart's image
Beam Therapeutics
Price$23.89
Change-$0.47 (-1.93%)
Volume$21.35K
CapitalizationN/A
Fate Therapeutics
Price$2.67
Change-$0.09 (-3.26%)
Volume$148.21K
CapitalizationN/A
View a ticker or compare two or three
BEAM vs FATE Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
FATE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
BEAM vs. FATE commentary
Nov 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and FATE is a Hold.

COMPARISON
Comparison
Nov 05, 2024
Stock price -- (BEAM: $24.36 vs. FATE: $2.76)
Brand notoriety: BEAM and FATE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 139% vs. FATE: 177%
Market capitalization -- BEAM: $2.01B vs. FATE: $314.3M
BEAM [@Biotechnology] is valued at $2.01B. FATE’s [@Biotechnology] market capitalization is $314.3M. The market cap for tickers in the [@Biotechnology] industry ranges from $498.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileFATE’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • FATE’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEAM and FATE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while FATE’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 3 bearish.
  • FATE’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than FATE.

Price Growth

BEAM (@Biotechnology) experienced а +8.99% price change this week, while FATE (@Biotechnology) price change was -3.83% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +14.28%, and the average quarterly price growth was +9.90%.

Reported Earning Dates

BEAM is expected to report earnings on Mar 04, 2025.

FATE is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.01B) has a higher market cap than FATE($314M). BEAM YTD gains are higher at: -10.507 vs. FATE (-26.203). BEAM has higher annual earnings (EBITDA): -162.88M vs. FATE (-176.34M). BEAM has more cash in the bank: 1.01B vs. FATE (305M). FATE has less debt than BEAM: FATE (101M) vs BEAM (165M). BEAM has higher revenues than FATE: BEAM (353M) vs FATE (12.3M).
BEAMFATEBEAM / FATE
Capitalization2.01B314M639%
EBITDA-162.88M-176.34M92%
Gain YTD-10.507-26.20340%
P/E RatioN/AN/A-
Revenue353M12.3M2,870%
Total Cash1.01B305M330%
Total Debt165M101M163%
FUNDAMENTALS RATINGS
FATE: Fundamental Ratings
FATE
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMFATE
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
86%
Declines
ODDS (%)
Bearish Trend 14 days ago
85%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
FATE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OGIYX50.780.06
+0.12%
Invesco Global Opportunities Y
RRMGX97.090.07
+0.07%
T. Rowe Price Mid-Cap Growth R
RMOYX22.45N/A
N/A
Victory RS Mid Cap Growth Y
GTTTX40.92N/A
N/A
Goldman Sachs Small Cp Val Insghts Inv
MYISX23.76N/A
N/A
Victory Integrity Small/Mid-Cap Value Y

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+6.24%
CRSP - BEAM
74%
Closely correlated
-0.28%
NTLA - BEAM
68%
Closely correlated
+2.30%
EDIT - BEAM
65%
Loosely correlated
-1.03%
DNLI - BEAM
65%
Loosely correlated
+0.59%
PRME - BEAM
64%
Loosely correlated
-1.49%
More

FATE and

Correlation & Price change

A.I.dvisor indicates that over the last year, FATE has been loosely correlated with ALLO. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if FATE jumps, then ALLO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FATE
1D Price
Change %
FATE100%
+13.58%
ALLO - FATE
55%
Loosely correlated
+10.29%
ABCL - FATE
53%
Loosely correlated
+5.49%
NTLA - FATE
53%
Loosely correlated
+2.30%
BEAM - FATE
52%
Loosely correlated
+6.24%
CRBU - FATE
52%
Loosely correlated
+5.66%
More